MIRA
Price
$0.64Alerts
Change
+$0.01 (+1.59%)
Updated
Nov 17, 11:34 AM (EDT)
Capitalization
23.97M
Intraday BUY SELL Signals
SCLX
Price
$0.62Alerts
Change
-$0.63 (-50.40%)
Updated
Nov 17, 11:55 AM (EDT)
Capitalization
11.96M
Intraday BUY SELL Signals
Interact to see
Advertisement

MIRA vs SCLX

MIRA vs SCLX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MIRA vs. SCLX commentary
Nov 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRA is a Hold and SCLX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MIRA with price predictions
Nov 16, 2026

MIRA's RSI Oscillator ascends from oversold territory

The RSI Indicator for MIRA moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 21 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on MIRA as a result. In 48 of 60 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for MIRA just turned positive on November 06, 2026. Looking at past instances where MIRA's MACD turned positive, the stock continued to rise in 24 of 29 cases over the following month. The odds of a continued upward trend are 83%.

Following a +6.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRA advanced for three days, in 103 of 125 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

MIRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for MIRA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.937) is normal, around the industry mean (-1.421). P/E Ratio (-0.468) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. MIRA's P/S Ratio (0.000) is slightly lower than the industry average of (4.033).

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. MIRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.

A.I.Advisor
a Summary for SCLX with price predictions
Nov 16, 2026

SCLX in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 16, 2026

SCLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 38 cases where SCLX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SCLX just turned positive on October 29, 2026. Looking at past instances where SCLX's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The 50-day moving average for SCLX moved below the 200-day moving average on October 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SCLX entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.039) is normal, around the industry mean (-1.421). P/E Ratio (-0.034) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.738). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (1.435) is also within normal values, averaging (4.033).

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. SCLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
MIRASCLX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 17, 2026
Stock price -- (MIRA: $0.63 vs. SCLX: $1.25)
Brand notoriety: MIRA and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MIRA: 30% vs. SCLX: 160%
Market capitalization -- MIRA: $23.97M vs. SCLX: $11.96M
MIRA [@Pharmaceuticals: Major] is valued at $23.97M. SCLX’s [@Pharmaceuticals: Major] market capitalization is $11.96M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.21T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $215.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRA’s FA Score shows that 1 FA rating(s) are green while SCLX’s FA Score has 2 green FA rating(s).

  • MIRA’s FA Score: 1 green, 4 red.
  • SCLX’s FA Score: 2 green, 3 red.
According to our system of comparison, both MIRA and SCLX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRA’s TA Score shows that 5 TA indicator(s) are bullish while SCLX’s TA Score has 2 bullish TA indicator(s).

  • MIRA’s TA Score: 5 bullish, 3 bearish.
  • SCLX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, MIRA is a better buy in the short-term than SCLX.

Price Growth

MIRA (@Pharmaceuticals: Major) experienced а +1.94% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -28.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.62%. For the same industry, the average monthly price growth was -0.24%, and the average quarterly price growth was +4.35%.

Industries' Descriptions

@Pharmaceuticals: Major (-2.62% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
Interact to see
Advertisement

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-4.36%
AMRN - MIRA
20%
Poorly correlated
-0.62%
GRFS - MIRA
17%
Poorly correlated
+0.46%
SNY - MIRA
15%
Poorly correlated
+0.04%
BIIB - MIRA
11%
Poorly correlated
-0.69%
AMGN - MIRA
10%
Poorly correlated
-0.72%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and AMRN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-12.59%
AMRN - SCLX
21%
Poorly correlated
-0.62%
BIIB - SCLX
20%
Poorly correlated
-0.69%
MIRA - SCLX
11%
Poorly correlated
-4.36%
ABBV - SCLX
6%
Poorly correlated
-0.16%
MDCX - SCLX
6%
Poorly correlated
-13.33%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTB219.78-1.34
-0.61%
M&T Bank Corp
GLDG0.70-0.03
-4.20%
GoldMining
RGTI9.06-0.56
-5.82%
Rigetti Computing
UPLD2.73-0.21
-7.14%
Upland Software
TBN27.11-2.14
-7.32%
Tamboran Resources Corp.